Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Pizzimenti

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Pharmaceutics|February 26, 2022
Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of MelanomaMonica Argenziano, Federica Bessone, Chiara Dianzani, et al.
PPAR Research|July 11, 2008
The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation ProductsGiuseppina Barrera, Cristina Toaldo, Stefania Pizzimenti, et al.
Current Medicinal Chemistry|December 7, 2016
Drug Delivery Nanoparticles in Treating Chemoresistant Tumor CellsGiuseppina Barrera, Martina Daga, Benedetta Ferrara, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Methanol Extract from <i>Ranunculus repens</i> L. Down-Regulated Galectins 4 and 9, and Mitigated Chronic Pancreatitis in an Experimental Rat ModelAmir Khenchil, Hocine Rechreche, Arbia Abbes, et al.
Antioxidants (Basel, Switzerland)|December 24, 2021
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted TherapiesStefania Pizzimenti, Simone Ribero, Marie Angele Cucci, et al.
Free Radical Biology & Medicine|April 28, 2007
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cellsAngelo Cerbone, Cristina Toaldo, Stefano Laurora, et al.
Antioxidants (Basel, Switzerland)|June 28, 2023
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in MelanomaMarie Angèle Cucci, Margherita Grattarola, Chiara Monge, et al.
Free Radical Biology & Medicine|November 22, 2008
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidationStefania Pizzimenti, Manuela Ferracin, Silvia Sabbioni, et al.
Cell Death & Disease|November 26, 2022
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilitiesCelia Sequera, Margherita Grattarola, Agnes Holczbauer, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 11, 2008
Down-regulation of Notch1 expression is involved in HL-60 cell growth inhibition induced by 4-hydroxynonenal, a product of lipid peroxidationStefania Pizzimenti, Giuseppina Barrera, Elisabetta Calzavara, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Pharmaceutics|February 26, 2022
Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of MelanomaMonica Argenziano, Federica Bessone, Chiara Dianzani, et al.
PPAR Research|July 11, 2008
The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation ProductsGiuseppina Barrera, Cristina Toaldo, Stefania Pizzimenti, et al.
Current Medicinal Chemistry|December 7, 2016
Drug Delivery Nanoparticles in Treating Chemoresistant Tumor CellsGiuseppina Barrera, Martina Daga, Benedetta Ferrara, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Methanol Extract from <i>Ranunculus repens</i> L. Down-Regulated Galectins 4 and 9, and Mitigated Chronic Pancreatitis in an Experimental Rat ModelAmir Khenchil, Hocine Rechreche, Arbia Abbes, et al.
Antioxidants (Basel, Switzerland)|December 24, 2021
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted TherapiesStefania Pizzimenti, Simone Ribero, Marie Angele Cucci, et al.
Free Radical Biology & Medicine|April 28, 2007
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cellsAngelo Cerbone, Cristina Toaldo, Stefano Laurora, et al.
Antioxidants (Basel, Switzerland)|June 28, 2023
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in MelanomaMarie Angèle Cucci, Margherita Grattarola, Chiara Monge, et al.
Free Radical Biology & Medicine|November 22, 2008
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidationStefania Pizzimenti, Manuela Ferracin, Silvia Sabbioni, et al.
Cell Death & Disease|November 26, 2022
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilitiesCelia Sequera, Margherita Grattarola, Agnes Holczbauer, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 11, 2008
Down-regulation of Notch1 expression is involved in HL-60 cell growth inhibition induced by 4-hydroxynonenal, a product of lipid peroxidationStefania Pizzimenti, Giuseppina Barrera, Elisabetta Calzavara, et al.
Pageof 8